animal disease model

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

4.220 documents for animal disease model

- Progenics' Humanized Monoclonal Antibodies Significantly Improve Survival in an Animal Model of C. difficile-associated Disease.
TARRYTOWN, N.Y. & BOSTON -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today presented preclinical findings for its humanized monoclonal antibodie...
- Business Wire
- September 13, 2010
- Alzheimer Disease Plaques Seen with Conventional Mri in Animal Model for the First Time
To: HEALTH EDITORS Contact: Alzheimer's Association media line: +1-312-335-4078, media@alz.org; or ICAD 2008 press room, July 27-31: +1-312-949-3253
- U.S. Newswire
- July 27, 2008
- Compugen Announces Positive Therapeutic Effects of Novel Peptide in Animal Model of Inflammatory Bowel Disease.
Novel Peptide Was Predicted Using Compugen's DAC Blockers Discovery Platform TEL AVIV, Israel -- Compugen Ltd. (NASDAQ:CGEN) announced today that CG...
- Business Wire
- June 23, 2009

- Request for Information (RFI): Input Into the Deliberations of the Council of Councils Working Group on the Use of Chimpanzees in NIH-Supported Research
The National Institutes of Health Council of Councils has established a working group to provide recommendations to the Council on: (1) Implementing the guiding principles and criteria contained within the Institute of Medicine report, ``Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity'', and (2) the size and placement of the research active and inactive populations of NIH- owned or -supported chimpanzees. See http://dpcpsi.nih.gov/council/ working--group.aspx for the working group's charge and roster. The NIH is seeking public input to inform the working group's deliberations. Background: The use of animals in research has enabled scientists to identify new ways to treat illness, extend life, and improve health and well-being. Chimpanzees are our closest relat...

... 2. There must be no other research model by which the knowledge could be obtained, and the ... development, prevention, or treatment of disease. The committee was unable to reach consensus on th...
- Federal Register Nbr. 77 FR 10760, February 23, 2012
- Notices
- National Institutes of Health
- AVR118 Suppresses Progression of Disease in Animal Model of Multiple Sclerosis Developed at The Weizmann Institute of Science.
Business Editors/Health/Medical Writers YONKERS, N.Y.--(BUSINESS WIRE)--Dec. 9, 2003 Advanced Viral Research Corp. (OTCBB: ADVR) today announced t...
- Business Wire
- December 09, 2003
- Okc-Based Charlesson Llc Receives Awards Totaling $1.6 Million From Nih
Charlesson LLC has been awarded two Small Business Innovative Research awards totaling $1.6 million from the National Institutes of Health. The Oklahoma City ocular biopharmaceutical company will use the money to support development of a nanoparticle-formulated therapy for eye disease and commercialization of a preclinical genetic animal model for age-related macular degeneration.
- The Journal Record
- April 24, 2008
- Hemoxymed to Market Unique Animal Model for Alzheimer's Disease; Genetically Altered Mice to be used by Industry to Develop new Therapeutics.
Business Editors/Health/Medical Writers VERNON HILLS, Ill.--(BUSINESS WIRE)--Sept. 16, 2003 Hemoxymed, Inc. (OTC BB:HMYD) today announced plans to...
- Business Wire
- September 16, 2003
- Rep. Jack Kingston Holds a Hearing On Agriculture Marketing Regulatory Programs Budget
... the agricultural sector from plant and animal health threats, and we help insure humane care and... the nation's agriculture from pests and disease. MRP also increases the efficiency of production ... support so that you do create a sustainable model that can meet both small and medium and large size...
- Political Transcript Wire
- March 14, 2011
- Titan Pharmaceuticals, Inc. Announces Publication Of Neural Regeneration Data In Animal Model Of Parkinson's Disease.
SOUTH SAN FRANCISCO, CA,--(BW HealthWire)--Oct. 9, 1997--Titan Pharmaceuticals, Inc. (NASDAQ: TTNP, TTNPU and TTNPW) today announced the publication i...
- Business Wire
- October 09, 1997
- COMPUGEN REPORTS NET LOSS OF $1.6 MIL FOR 3RD QTR 2010.
...'s president and CEO stated, "Our business model is to utilize our systematic and broadly applicabl... by advancing selected molecules beyond the animal disease model proof of concept, something we have ...
- Biotech Financial Reports
- Vol. 17 Nbr. 11, November 2010